Beta Amyloid 42 Measurement

Known as: Amyloid Beta 1-42 Measurement, Amyloid Beta 42 Protein, Beta Amyloid 1-42 Measurement 
The determination of the amount of the 1-42 amino acid beta amyloid protein isoform present in a sample.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2018
05101519992018

Related topics

Related topics

3 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium Terminology

Related mentions per year

Related mentions per year

1992-2018
1990200020102020
Beta Amyloid 42 Measurement
Clinical Data Interchange Standards Consortium Terminology
CDISC SDTM Laboratory Test Terminology by Code
CDISC SDTM Laboratory Test Terminology by Name

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
The transmembrane protein CD33 is a sialic acid-binding immunoglobulin-like lectin that regulates innate immunity but has no… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
NF-кB-regulated micro RNAs (miRNAs) in primary human brain cells.
Micro RNAs (miRNAs), small and labile ~22 nucleotide-sized fragments of single stranded RNA, are important regulators of… (More)
Is this relevant?
2010
2010
Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells.
Human brains harbor herpes simplex virus type-1 (HSV-1) DNA, which normally remains quiescent throughout many decades of life… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.
BACKGROUND To date, there have been no reports of individuals who have been characterized longitudinally using clinical and… (More)
Is this relevant?
2009
2009
Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury.
OBJECT Damage to axons contributes to postinjury disabilities and is commonly observed following traumatic brain injury (TBI… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease.
Microglia are the immune cells of the brain, they are activated in the brain of Alzheimer's disease (AD) patients and mouse… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
The changes of plasma amyloid beta (Abeta42) protein, homocysteine and medial temporal lobe atrophy (MTA) were studied by the… (More)
Is this relevant?
2005
2005
CpG-containing oligodeoxynucleotide promotes microglial cell uptake of amyloid beta 1-42 peptide by up-regulating the expression of the G-protein- coupled receptor mFPR2.
Human G protein-coupled formyl peptide receptor like 1 (FPRL1) and its mouse homologue murine formyl peptide receptor 2 (mFPR2… (More)
Is this relevant?
2004
2004
Mean age of onset in familial Alzheimer ’ s disease is determined by amyloid beta 42
  • Marco Dueringa, Marcus O. W. Grimma, Heike S. Grimma, Johannes Schröderb, Tobias Hartmanna
  • 2004
10 More than 130 known mutations in the presenilin-1 (PS1) gene result in familial Alzheimer’s disease (FAD) with a mutation… (More)
  • figure 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity.
Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with a lower risk of developing Alzheimer's disease… (More)
Is this relevant?